

Hi, I’m Dean, Director of Scientific Engagement, Oncology at CrownBio. Thanks for visiting my poster. Please contact me to discuss my research using the link to the right.
Comparison of Illumina NovaSeq 6000 and MGISEQ-2000 in Profiling Xenograft Models
Evaluating variation in drug efficacy endpoints in a syngeneic mouse model (CT26.WT) under immune checkpoint blockade
In Vitro Characterization of Antibodies Targeting the SIRPa–CD47 Phagocytosis Checkpoint using Tumor-Associated Macrophages from HuGEMM™ Mice
Characterization of a Humanized TLR8 Mouse Model and its Application in Immuno-Oncology Drug Development
Tracing T Cell Activation Cytokines in Reporter Models by Bioluminescent Imaging
In vitro and in vivo characterization of human CD3EDG triple knock in mice (CD3EDG Hu GEMM™ ) for CD3 bispecific antibodies
Anti-human TNFR2 antagonist induces T cell proliferation and restores T cell balance to promote tumor killing in TNFR2HuGEMM™ engrafted with MC38-OVA tumor cells
Detection of Structural Variation and Analysis on HuKemia™ models by Using Bionano Optical Mapping
NGS-Based Murine Pan-Cancer Gene Expression Panel Reveals High Resolution for Immuno-Oncology and Tumor Microenvironment Studies
Establishment and Characterization of a Series of Murine Cancer Homograft Models Derived from Induced Cancer Stem Cells
The Impact of Drinking Water PH on Anti-PD-1 Efficacy in Syngeneic Mouse Models
Establishment and Characterization of a series of Lymphoma PDX models to represent varied clinical behaviors and treatment responses
Characterization of a panel of orthotopic bioluminescent patient-derived models for drug discovery
An ultra-accurate NGS assay reveals great variation in mouse ratios in xenograft tumors by mouse strain and cancer type
Hi, I’m Dean, Director of Scientific Engagement, Oncology at CrownBio. Thanks for visiting my poster. Please contact me to discuss my research using the link to the right.